Mutational signatures associated with defective HR can be grouped into two classes (Meier et al. 2021): one, mutants lacking BRC-1, RAD-51, or RAD51 paralogs show elevated base substitutions, indels, and SVs, features observed in brca1-defective cancer genomes and in mammalian mutation accumulation lines. Here, RAD51 is linked to cancer.